Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer

NCT00159094 is registered in ClinicalTrials.gov with Hematology Oncology Consultants as lead sponsor.

NCT NCT00159094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00159094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer
Lead sponsor
Hematology Oncology Consultants
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2003
Completion date
Not reported
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer